NCT01057433View on ClinicalTrials.gov

Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Pitavastatin (NK-104)

pitavastatin (NK-104) 4 mg once daily (QD)

DRUG

Lopinavir/ritonavir

lopinavir/ritonavir 800 mg/200 mg

Trial Locations (1)

Unknown

Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY